Press release from Companies: DanCann Pharma A/S: Strong Support from the DanCann Pharma Board of Directors, who convert their warrants into shares and buy more than 80,000 shares equaling DKK +400,000

Press release from Companies: DanCann Pharma A/S: Strong Support from the DanCann Pharma Board of Directors, who convert their warrants into shares and buy more than 80,000 shares equaling DKK +400,000

Press release from Companies: DanCann Pharma A/S Announces Exercise of Warrants for Proceeds of DKK approx. DKK 9.3 million to Strengthen the Financial Position

Press release from Companies: DanCann Pharma A/S: EUROPEAN UNION INTELLECTUAL PROPERTY OFFICE CERTIFICATE OF REGISTRATION for product portfolio trademarks

Press release from Companies: DanCann Pharma A/S: Morten Martinsen, COO, sells minor position of shares in DanCann Pharma

Press release from Companies: DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe

Press release from Companies: DanCann Pharma A/S: CEO, Jeppe Krog Rasmussen (Xignotus Capital ApS), locks his position in DanCann Pharma for 3 years - and thereby more than 21% of the total share capital

Press release from Companies: DanCann Pharma A/S: It's official: A permanent scheme for medical cannabis in Denmark

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™

Press release from Companies: DanCann Pharma A/S publishes Q3-2021 report

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency

Press release from Companies: DanCann Pharma A/S: Correction: Flagging announcement in DanCann Pharma A/S